<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03572712</url>
  </required_header>
  <id_info>
    <org_study_id>RC18_0017</org_study_id>
    <nct_id>NCT03572712</nct_id>
  </id_info>
  <brief_title>Usefulness of Transcutaneous Capnography to Assess Residual Hypoventilation in Obesity-Hypoventilation Syndrom Treated by Non Invasive Ventilation at Home : a Prospective Study</brief_title>
  <acronym>PtcCO2-SOH</acronym>
  <official_title>Usefulness of Transcutaneous Capnography to Assess Residual Hypoventilation in Obesity-Hypoventilation Syndrom Treated by Non Invasive Ventilation at Home : a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcutaneous capnography (PtcCo2) recently showed good agreement with blood gases to assess&#xD;
      hypercapnia. There is no study that has evaluated the benefit to realise systematically a&#xD;
      nocturnal PtcCo2 in the follow-up of home-ventilated patient with obesity hypoventilation&#xD;
      syndrome (OHS). The investigators will evaluate the intake bring by nocturnal transcutaneous&#xD;
      capnography, compared to nocturnal oximetry and blood gases, to diagnose nocturnal alveolar&#xD;
      hypoventilation in a population of patient presenting an OHS, treated by non invasive&#xD;
      ventilation (NIV) at home .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be evaluated once a year in consultation with a blood gases, and then a&#xD;
      nocturnal recording at home including a transcutaneous capnography and an oximetry.&#xD;
&#xD;
      Some data will be registered too : cardiovascular and neurological comorbidities, diabetes&#xD;
      mellitus, treatment, parameters of the non-invasive ventilation, duration of compliance and&#xD;
      apnea-hypopnea index (if available).&#xD;
&#xD;
      The investigators will perform a sequential analysis of nocturnal hypoventilation with first&#xD;
      blood gases, then nocturnal oxymetry and to finish nocturnal PtcCo2. It will allow us to&#xD;
      determine if PtcCo2 catch up some nocturnal hypoventilation, undetected by the first two&#xD;
      exams.&#xD;
&#xD;
      The investigators plan that the study will last 18 months. The analysis will be descriptive.&#xD;
      Quantitative variables will be described with mean, standard deviation, minimum, maximum and&#xD;
      median. Quantitative variables are presented with number and percentage.&#xD;
&#xD;
      Comparison of blood gas / oximetry association with blood gas / oximetry / transcutaneous&#xD;
      capnography using a McNemar test&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 14, 2018</start_date>
  <completion_date type="Actual">November 21, 2019</completion_date>
  <primary_completion_date type="Actual">November 21, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>nocturnal hypoventilation</measure>
    <time_frame>Until 37 days</time_frame>
    <description>Nocturnal PtcCo2 &gt; 49 mmHg more than 10% of sleeping time</description>
  </primary_outcome>
  <enrollment type="Actual">32</enrollment>
  <condition>Obesity Hypoventilation Syndrome</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Interventional study</intervention_name>
    <description>every patient will be monitored with a blood gase, a nocturnal oximetry and a transcutaneous capnography</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The pneumology department at Nantes University Hospital follows approximately 400 patients&#xD;
        treated by non-invasive ventilation, 250 of whom have SOH The investigators plan to include&#xD;
        150 patients in the active patient line followed at Nantes University Hospital, which will&#xD;
        make it possible to obtain the number of patients necessary to obtain satisfactory power&#xD;
        while taking into account the fact that a certain number of transcutaneous capnographies&#xD;
        will not be conclusive.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Obesity Hypoventilation Syndrom defined by a diurnal PaCo2&gt; 45 mmHg, in stable&#xD;
             conditions, in a patient presenting an obesity (BMI &gt; 30 kg/mÂ²)&#xD;
&#xD;
          -  treated by non invasive ventilation since at least 3 weeks, and seen in follow-up&#xD;
             consultation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  minors&#xD;
&#xD;
          -  refusal to participate&#xD;
&#xD;
          -  under guardianship or trusteeship&#xD;
&#xD;
          -  pregnant woman&#xD;
&#xD;
          -  other etiology of hypoventilation : copd, kyphoscoliosis, neuromuscular disorders,&#xD;
             diaphragmatic pathology&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 13, 2018</study_first_submitted>
  <study_first_submitted_qc>June 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2018</study_first_posted>
  <last_update_submitted>December 22, 2020</last_update_submitted>
  <last_update_submitted_qc>December 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity Hypoventilation Syndrome</keyword>
  <keyword>Non Invasive Ventilation</keyword>
  <keyword>Transcutaneous capnography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

